Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Patients treated with Immune checkpoint inhibitors (ICIs) were more likely to develop hypertension within a year than those untreated with ICIs. It is therefore plausible that ICIs may increase the risk of developing hypertension in cancer patients.
siehe auch:
Unerwünschte Ereignisse / Sicherheit & Immune-Checkpoint-Inhibitoren (ICIs)
…